Key result
Valved conduits linked to ~218% higher long-term mortality versus valve-sparing procedures in Marfan syndrome.
Why the study?
While valve-sparing procedures show favorable results in aortic root surgery, their feasibility in patients with Marfan syndrome remains questionable.
Do valve-sparing approaches improve long-term outcomes compared to valved conduits in patients with Marfan syndrome undergoing aortic root surgery?
Meta-Analysis
Do valve-sparing approaches improve long-term outcomes compared to valved conduits in patients with Marfan syndrome undergoing aortic root surgery?
Odds Ratio: 3.18 (95% CI 1.8–5.63)
p-value: p=<0.0001
Valve-sparing procedures in patients with Marfan syndrome offer advantages in reducing long-term mortality and postoperative complications compared to valved conduits, despite a higher risk of severe aortic insufficiency.
May warrant valve-sparing preference in Marfan syndrome aortic surgery; leaves open randomized confirmation of survival benefit.
Valve-sparing procedures in aortic root surgery demonstrate favorable short-term and long-term results. At the same time, the feasibility of valve-sparing procedures in patients with Marfan syndrome is questionable. This meta-analysis compares the immediate and long-term results of valve-sparing approaches and valved conduits in aortic root surgery for patients with Marfan syndrome. Data searching was performed in the MEDLINE, Embase, Cochrane and Web of Science databases. The primary endpoints were redo surgery rate and mortality in long-term period. Long-term aortic insufficiency (AI) +3/+4 was also estimated as a primary endpoint. Secondary endpoints included surgery for acute aortic dissection type A, 30-day mortality, thromboembolism, endocarditis and bleeding. Meta-analysis was carried out in accordance with the PRISMA recommendations 2020. In-hospital mortality was similar (OR 3.46; 95% CI 0.92—12.92; I2=0%; p=0.07). In long-term period, thromboembolism (OR 2.77; 95% CI 1.44—5.33; I2=0%; p=0.002), endocarditis (OR 3.19; 95% CI 1.18—8.61; I2=0%; p=0.02), bleeding (OR 3.46; 95% CI 1.76—6.77; I2=0%; p=0.0003) and mortality (OR 3.18; 95% CI 1.8—5.63; I2=12%; p<0.0001) were significantly more common after implantation of valved conduits. In long-term period, aortic insufficiency +3/+4 was more common after reimplantation (OR 0.17; 95% CI 0.05—0.52; I2=5%; p=0.002). In our study, valve-sparing procedures have advantage regarding the incidence of postoperative complications and mortality. However, long-term freedom from severe aortic insufficiency was higher after implantation of valved conduits.
No takes yet. Share an insight, caveat, or question.
Isaev et al. (2024) conducted a meta-analysis in Marfan syndrome requiring aortic root surgery. Valve-sparing approaches vs. Valved conduits was evaluated on Long-term mortality (OR 3.18, 95% CI 1.8-5.63, p=<0.0001). Implantation of valved conduits in patients with Marfan syndrome was associated with significantly higher long-term mortality compared to valve-sparing procedures (OR 3.18; 95% CI 1.8-5.63; p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: